top of page
myLaminin Perspectives
Insights on Research Compliance, Clinical Trials & Data Management
Managing Protocol Deviations and Amendments in Multi-Site Clinical Trials at Scale
earn how sponsors can manage protocol deviations, amendments, eTMF documentation, and regulatory compliance in multi-site clinical trials under evolving ICH E6(R3) expectations.
myLaminin
May 257 min read
ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now
ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val
Deanne Bassili
May 74 min read
bottom of page